Medlive Technology Co (FRA:1JZ) Other Financing: €-0.55 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:1JZ Medlive Technology Co Ltd FRA:1JZ
90 GF Score
Price €0.84
GF Value €1.61
! 5 Warning Signs
View Full Analysis

What is Medlive Technology Co Other Financing?

Medlive Technology Co FRA:1JZ +2.93% 90 Other Financing is €-0.55 Mil as of Dec. 2025. GuruFocus rates FRA:1JZ with a GF Score™ of 90/100 and a GF Value™ of €1.61. The stock has 5 warning signs investors should review.

Medlive Technology Co's Other Financing for the six months ended in Dec. 2025 was €0.03 Mil.

Medlive Technology Co's Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.55 Mil.

Medlive Technology Co Other Financing Historical Data

* Premium members only.

The historical data trend for Medlive Technology Co's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medlive Technology Co Other Financing Chart

Medlive Technology Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial -20.19 -0.71 -1.05 -1.07 -0.74

Medlive Technology Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.24 -0.86 0.10 -0.57 0.03
FRA:1JZ
90GF Score
Medlive Technology Co Ltd FRA:1JZ
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medlive Technology Co Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.55 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of €-0.55 Mil mean?
Medlive Technology Co (FRA:1JZ) has a Other Financing of €-0.55 Mil as of Dec. 2025. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Medlive Technology Co and its competitors.
Is Medlive Technology Co's Other Financing too high?
Medlive Technology Co's current Other Financing is €-0.55 Mil. Overall, Medlive Technology Co has a GF Score™ of 90/100, reflecting its overall financial health beyond just this single metric.
How does Medlive Technology Co's Other Financing compare to VEEV and BTSG?
Medlive Technology Co's Other Financing of €-0.55 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Healthcare Providers & Services company?
A good Other Financing depends on the Healthcare Providers & Services industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Medlive Technology Co and its competitors. Medlive Technology Co's current Other Financing is €-0.55 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medlive Technology Co stock overvalued right now?
Medlive Technology Co (FRA:1JZ) has a current Other Financing of €-0.55 Mil. The stock's GF Value™ is €1.61, compared to a current price of €0.84 — trading 47.6% below its estimated fair value. The current Other Financing is €-0.55 Mil. Medlive Technology Co's overall GF Score™ is 90/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Medlive Technology Co (FRA:1JZ), the current Other Financing is €-0.55 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medlive Technology Co (FRA:1JZ) Overvalued in 2026?

Based on GuruFocus' analysis, Medlive Technology Co stock appears to be undervalued. The current stock price of €0.84 is trading 47.6% below its estimated GF Value™ of €1.61.

Key valuation signals for FRA:1JZ:

  • Other Financing: €-0.55 Mil
  • GF Value™: €1.61 vs. price of €0.84 (47.6% below fair value)
  • GF Score™: 90/100 with 5 warning signs

No single metric tells the full story. See the FRA:1JZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medlive Technology Co Business Description

Other Exchanges 02192:Hong Kong
Address Huangqu East Road No. 5, Courtyard Building 4, Yimaitong Mansion, Chaoyang District, Beijing, CHN
Medlive Technology Co Ltd is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms. The company developed into a professional provider of medical information services and precision digital marketing services. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and a SaaS solution that helps with medical conferences and clinical research.
90GF Score

Get the complete analysis for FRA:1JZ

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.84
Price
€1.61
GF Value